News | July 26, 2021
Glenmark Life Sciences IPO to open on July 27, 2021
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
Subscribe To Our Newsletter & Stay Updated
